NasdaqCM - Nasdaq Real Time Price • USD
Inovio Pharmaceuticals, Inc. (INO)
As of 10:28 AM EDT. Market Open.
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 3 |
Avg. Estimate | -0.99 | -0.97 | -3.93 | -3.39 |
Low Estimate | -1.17 | -1.15 | -4.64 | -4.41 |
High Estimate | -0.86 | -0.82 | -3.2 | -2.85 |
Year Ago EPS | -1.92 | -1.56 | -6.09 | -3.93 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 5 | 4 |
Avg. Estimate | 190k | 190k | 600k | 7.02M |
Low Estimate | 100k | 100k | -- | -- |
High Estimate | 250k | 250k | 1M | 17.08M |
Year Ago Sales | 114k | 226k | 832k | 600k |
Sales Growth (year/est) | 66.70% | -15.90% | -27.90% | 1,070.00% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -1.74 | -1.74 | -1.52 | -1.27 |
EPS Actual | -1.92 | -1.56 | -1.56 | -1.12 |
Difference | -0.18 | 0.18 | -0.04 | 0.15 |
Surprise % | -10.30% | 10.30% | -2.60% | 11.80% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.99 | -0.97 | -3.93 | -3.39 |
7 Days Ago | -0.99 | -0.97 | -3.93 | -3.39 |
30 Days Ago | -0.99 | -0.97 | -3.93 | -3.39 |
60 Days Ago | -0.83 | -0.8 | -3.57 | -2.64 |
90 Days Ago | -0.84 | -0.84 | -3.63 | -3.04 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | INO | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 48.40% | -- | -- | 1.50% |
Next Qtr. | 37.80% | -- | -- | 11.40% |
Current Year | 35.50% | -- | -- | 5.20% |
Next Year | 13.70% | -- | -- | 13.40% |
Next 5 Years (per annum) | 41.50% | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Oppenheimer: Outperform to Outperform | 3/8/2024 |
Reiterates | RBC Capital: Sector Perform to Sector Perform | 3/7/2024 |
Upgrade | Oppenheimer: Perform to Outperform | 1/25/2024 |
Related Tickers
VXRT Vaxart, Inc.
0.7198
+1.44%
NVAX Novavax, Inc.
4.0150
-3.25%
OCGN Ocugen, Inc.
1.1300
-4.24%
SRNE Sorrento Therapeutics, Inc.
0.0200
0.00%
IBIO iBio, Inc.
1.8100
-4.62%
MRNA Moderna, Inc.
105.37
-3.20%
ALT Altimmune, Inc.
7.22
+1.98%
AGEN Agenus Inc.
7.60
+2.43%
IBRX ImmunityBio, Inc.
4.9988
+3.71%
BNTX BioNTech SE
86.62
-1.67%